‘Stick to the plan and listen to your investors’
Fireside Chat: ‘Communicating to investors through a crisis’ Chaired by Mary Clark, with Kevin Mannix, Head of IR at Teva, and Oliver Maier, Head of IR at Bayer
Strategy and Core Values at the Heart of Pandemic Crisis Response
Fireside Chat with Dan Mahony, Co-head of Healthcare, Polar Capital & Kieran Murphy, President & CEO, GE Healthcare
Radio what’s new? Tuning in to turning cancer cells off
Tuning in to the field of targeted cancer medicine through molecular radiotherapy or targeted radionuclides.
Sanofi offers to acquire Kiadis for €308 million
Congratulations to Kiadis Pharma on recently announcing that it is being acquired by Sanofi in a deal valued at approximately €308m ($359m), a 272% premium over last week’s closing price, one of the largest premiums in European biotech. After the discontinuation of its lead product candidate and subsequent reorganization in 2019, Kiadis started 2020 as an entirely new company […]
Covid-19: The Industry Response – How Are we Doing?
Chair: Clive Cookson, Science Editor, Financial Times Sean Marett, Chief Business and Chief Commercial Officer, BioNTech Professor James Logan, Head of Department of Disease Control, London School of Hygiene and Tropical Medicine Kate Bingham, Chair of UK Vaccine Taskforce & Managing Partner of SV Health Investors Rajeev Venkayya, MD, President Global Vaccine Business Unit, Takeda […]
